Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

VANCOUVER, British Columbia, Oct. 16, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company...

Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its news release dated May 21, 2019, the Canadian Securities Exchange (the “CSE”) has conditionally accepted its proposed transaction (the “Transaction”) with Isracann Biosciences Inc. (“Isracann”), which is...

Atlas Blockchain Closes $10.1MM Total Financing for Proposed Acquisition of Israeli Cannabis Operation

–Related News– Company prepares to service growing European demand for quality high grade products VANCOUVER, British Columbia, May 21, 2019 — Atlas Blockchain Group Inc.  (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) is pleased to announce that it has has closed a second tranche of its recently announced private placement, raising total gross...

Atlas Blockchain to Acquire Isracann Biosciences Inc. and Complete Concurrent Financing for Up to $15 Million

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 16, 2018 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc.  (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) today provides an update detailing term particulars concerning a proposed concurrent financing as previously announced on October 11, 2018...